Nifty
Sensex
:
:
11896.80
40544.37
23.75 (0.20%)
112.77 (0.28%)

Pharmaceuticals & Drugs

Rating :
N/A  (View)

BSE: 526707 | NSE: ALCHEM

4.55
0.10 (2.25%)
20-Oct-2020 | 3:46PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  4.45
  •  4.70
  •  4.35
  •  4.45
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  19365
  •  0.88
  •  7.75
  •  0.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6.21
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 766.48
  • N/A
  • -0.03

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.94%
  • 0.00%
  • 50.51%
  • FII
  • DII
  • Others
  • 0%
  • 1.51%
  • 13.04%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -23.63
  • -40.20
  • 3.44

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.69
  • 12.74

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 6.79
  • -22.67

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.29
  • 0.23
  • -0.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -28.90
  • -51.08
  • -66.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
1
6
-86%
1
6
-78%
3
6
-59%
5
6
-23%
Expenses
1
7
-88%
49
8
503%
4
8
-50%
5
73
-93%
EBITDA
0
-1
-
-48
-2
-
-1
-2
-
-1
-67
-
EBIDTM
5%
-16%
-3,745%
-43%
-52%
-25%
-14%
-1,115%
Other Income
0
0
1500%
0
0
122%
0
1
-95%
0
0
400%
Interest
0
0
-67%
0
0
-50%
0
0
-17%
0
0
-82%
Depreciation
2
2
-7%
2
2
-2%
2
2
-3%
2
2
-5%
PBT
-1
-3
-
-50
-4
-
-3
-3
-
-2
-69
-
Tax
0
0
-20%
-10
-12
-
-2
0
-
0
1
-70%
PAT
-2
-3
-
-40
7
-
-1
-3
-
-3
-70
-
PATM
-185%
-50%
-3,095%
130%
-56%
-47%
-55%
-1,165%
EPS
-1.15
-2.15
-
-29.24
5.46
-
-1.08
-2.21
-
-1.88
-51.31
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
9
27
27
24
105
350
1,508
1,457
886
503
396
Net Sales Growth
-61%
1%
10%
-77%
-70%
-77%
3%
65%
76%
27%
 
Cost Of Goods Sold
6
20
19
19
65
289
1,417
1,369
813
432
336
Gross Profit
3
7
8
5
40
60
91
89
73
71
61
GP Margin
34%
26%
28%
22%
38%
17%
6%
6%
8%
14%
15%
Total Expenditure
59
80
36
53
138
375
1,476
1,417
852
468
364
Power & Fuel Cost
-
1
1
1
8
6
5
5
4
3
3
% Of Sales
-
2%
3%
3%
7%
2%
0%
0%
0%
1%
1%
Employee Cost
-
7
10
15
38
40
22
17
12
10
9
% Of Sales
-
28%
36%
61%
36%
12%
1%
1%
1%
2%
2%
Manufacturing Exp.
-
1
1
2
3
5
8
7
5
5
4
% Of Sales
-
3%
4%
9%
3%
2%
1%
0%
1%
1%
1%
General & Admin Exp.
-
2
2
3
13
17
11
8
8
7
8
% Of Sales
-
6%
8%
13%
13%
5%
1%
1%
1%
1%
2%
Selling & Distn. Exp.
-
2
2
5
8
13
8
8
5
5
3
% Of Sales
-
7%
9%
19%
8%
4%
1%
1%
1%
1%
1%
Miscellaneous Exp.
-
48
1
9
4
4
5
4
4
6
3
% Of Sales
-
179%
5%
38%
4%
1%
0%
0%
0%
1%
0%
EBITDA
-50
-53
-10
-29
-33
-26
32
41
34
35
32
EBITDA Margin
-533%
-199%
-36%
-121%
-32%
-7%
2%
3%
4%
7%
8%
Other Income
0
1
2
3
22
22
22
16
12
1
2
Interest
0
1
2
2
5
5
4
7
4
4
7
Depreciation
7
7
8
8
26
23
15
12
11
10
8
PBT
-57
-61
-17
-37
-42
-31
35
38
31
22
19
Tax
-11
-11
0
-1
2
-1
15
9
7
9
4
Tax Rate
20%
18%
-3%
1%
-3%
2%
55%
25%
23%
40%
23%
PAT
-45
-50
-17
-107
-48
-36
14
27
24
13
15
PAT before Minority Interest
-45
-50
-17
-107
-53
-38
12
28
24
13
15
Minority Interest
0
0
0
0
5
3
2
-1
0
0
0
PAT Margin
-483%
-186%
-64%
-444%
-46%
-10%
1%
2%
3%
3%
4%
PAT Growth
0%
-194%
84%
-122%
-35%
-352%
-48%
14%
83%
-14%
 
EPS
-33.35
-36.50
-12.43
-78.92
-35.57
-26.29
10.41
19.99
17.57
9.58
11.08

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
-150
-100
-83
35
87
136
178
105
121
156
Share Capital
14
14
14
14
14
14
27
28
41
53
Total Reserves
-163
-113
-97
21
73
122
151
74
81
103
Non-Current Liabilities
755
756
747
758
737
812
325
326
187
128
Secured Loans
0
3
6
6
11
19
27
23
23
35
Unsecured Loans
755
742
729
713
687
754
267
279
146
81
Long Term Provisions
1
1
1
2
4
4
3
2
2
0
Current Liabilities
164
166
172
197
192
193
44
81
86
43
Trade Payables
132
133
137
147
140
146
9
8
12
20
Other Current Liabilities
28
29
30
38
39
39
26
58
58
21
Short Term Borrowings
4
4
4
12
13
7
7
9
10
0
Short Term Provisions
0
0
1
0
0
2
3
6
6
2
Total Liabilities
770
822
835
999
1,030
1,159
566
512
394
327
Net Block
147
154
162
405
433
276
235
200
193
173
Gross Block
215
215
216
453
549
368
312
265
247
218
Accumulated Depreciation
68
61
55
49
116
92
77
65
54
45
Non Current Assets
332
336
346
445
481
500
460
359
303
242
Capital Work in Progress
0
0
0
19
27
202
201
135
74
45
Non Current Investment
169
169
171
2
2
2
2
2
23
24
Long Term Loans & Adv.
16
13
13
19
20
20
22
23
13
0
Other Non Current Assets
1
1
1
0
0
0
0
0
0
0
Current Assets
438
486
489
554
548
658
104
150
86
81
Current Investments
0
0
0
0
0
0
0
0
0
0
Inventories
1
2
6
41
44
45
40
39
36
30
Sundry Debtors
425
472
470
498
474
410
16
27
21
17
Cash & Bank
2
3
4
5
13
189
39
79
22
21
Other Current Assets
9
0
0
0
16
15
9
5
7
13
Short Term Loans & Adv.
8
10
9
10
16
14
9
5
6
13
Net Current Assets
273
320
317
358
356
465
60
69
0
38
Total Assets
770
822
835
999
1,030
1,159
566
512
394
327

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
-7
-14
-14
-25
-98
-232
4
15
15
23
PBT
-61
-16
-108
-42
-31
35
38
31
22
25
Adjustment
55
8
80
26
5
-5
-2
5
12
10
Changes in Working Capital
-1
-6
14
-8
-72
-252
-25
-21
-13
0
Cash after chg. in Working capital
-7
-14
-14
-25
-98
-222
10
15
21
34
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
0
0
0
0
0
-10
-6
0
-5
-4
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-3
4
5
-2
-9
-45
-98
-50
-65
-24
Net Fixed Assets
0
1
8
4
-5
-36
-65
-36
172
-20
Net Investments
0
2
73
-139
0
0
0
19
-99
0
Others
-3
0
-76
133
-4
-9
-33
-34
-138
-4
Cash from Financing Activity
9
10
11
19
-69
427
53
92
51
-1
Net Cash Inflow / Outflow
-1
0
1
-8
-175
150
-40
57
1
-2
Opening Cash & Equivalents
-1
-1
-2
13
189
39
79
22
21
23
Closing Cash & Equivalent
-2
-1
-1
5
13
189
39
79
22
21

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
-110
-74
-61
25
64
100
120
65
72
90
ROA
-6%
-2%
-12%
-5%
-4%
1%
5%
5%
4%
5%
ROE
0%
0%
0%
-88%
-35%
8%
23%
28%
13%
14%
ROCE
-9%
-2%
-15%
-6%
-4%
5%
10%
10%
9%
10%
Fixed Asset Turnover
0.12
0.12
0.07
0.21
0.77
4.43
5.06
3.47
2.17
1.90
Receivable days
6,123
6,460
7,314
1,670
460
51
5
10
14
16
Inventory Days
20
53
353
146
46
10
10
15
24
24
Payable days
1,302
1,368
988
356
137
19
2
4
13
19
Cash Conversion Cycle
4,841
5,145
6,679
1,460
370
43
13
21
25
22
Total Debt/Equity
-5.10
-7.54
-8.90
21.21
8.30
5.79
1.76
3.32
1.58
0.76
Interest Cover
-43
-9
-47
-9
-7
8
6
8
6
4

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.